Table 4.

Clinical, histologic, and molecular data for cases that received a sentinel lymph node biopsy

Sample IDDisease statusHistopathologic subtypeAgeGenderAnatomic siteBreslow depthUlceration statusSLN statusLength of follow-up (months)Gene expression score
9MalignantNodular melanoma54MLeft thigh6PresentPositive85.2
12MalignantSuperficial spreading melanoma60MRight shoulder0.45AbsentNegative41.5
22MalignantSuperficial spreading melanoma76FLeft lower leg2.18AbsentPositive123.8
24MalignantNodular melanoma80MRight scapula1.93PresentNegative378.1
25MalignantAcral lentiginous melanoma73MLeft foot4.4AbsentPositive189.4
91MalignantNodular melanoma56MLeft leg6PresentPositive1448.6
94MalignantNevoid melanoma34MRight abdomen1.25PresentNegative426.7
96MalignantNodular melanoma44FRight upper back6.59AbsentPositive66.7
140MalignantSuperficial spreading melanoma53MBack1.2AbsentNegative796
143MalignantAcral lentiginous melanoma69MLeft foot4.1AbsentNegative105.7
144MalignantSuperficial spreading melanoma75FRight lower leg0.67AbsentNegative222.6
145MalignantNodular melanoma70FRight posterior thigh1.25AbsentNegative666.6
159MalignantNevoid melanoma51MBack8AbsentPositive603.1
182MalignantNevoid melanoma71FScalp1.9AbsentNegative133.5
  • Abbreviations: F, female; M, male; SLN, sentinel lymph node.